ConductScience.org, home

Paper9862371

Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use.

Plebanski M and 10 others. Eur J Immunol, 1998. Cited by 76 papers, by iCite.

Cite this record

ConductScience Library. Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use. Papers, record 9862371. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9862371

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use.
PubMed
Journal
Eur J Immunol
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
76
iCite
Relative citation ratio, by iCite
1.64
iCite
Revised in PubMed
2018-05-09
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Plebanski MM
2Gilbert SCS C
3Schneider JJ
4Hannan CMC M
5Layton GG
6Blanchard TT
7Becker MM
8Smith GG
9Butcher GG
10Sinden RER E
11Hill AVA V

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, ProtozoanMajor topic
Drug Delivery SystemsMajor topic
Histocompatibility Antigens Class IMajor topic
MalariaMajor topic
Malaria VaccinesMajor topic
Plasmodium bergheiMajor topic
T-LymphocytesMajor topic
Animals
Cytotoxicity, Immunologic
Humans
Mice
Recombinant Proteins

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Wellcome TrustUnited KingdomPubMed

Source PubMed

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02925403A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 AdjuvantBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.

PMIDTitleJournalYearIn PapersSource
42342712BCG enables protection against malaria through adjuvanting an adenovirus-vectored vaccine.NPJ Vaccines2026https://conductscience.org/library/papers/42342712PubMed
36002507STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines.Sci Rep2022https://conductscience.org/library/papers/36002507PubMed
32153565Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.Front Immunol2020https://conductscience.org/library/papers/32153565PubMed
28779101Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria.Sci Rep2017https://conductscience.org/library/papers/28779101PubMed
28261200Vaccination with Altered Peptide Ligands of a Plasmodium berghei Circumsporozoite Protein CD8 T-Cell Epitope: A Model to Generate T Cells Resistant to Immune Interference by Polymorphic Epitopes.Front Immunol2017https://conductscience.org/library/papers/28261200PubMed
26590432The March Toward Malaria Vaccines.Am J Prev Med2015https://conductscience.org/library/papers/26590432PubMed
26350599Small Wonders-The Use of Nanoparticles for Delivering Antigen.Vaccines (Basel)2015https://conductscience.org/library/papers/26350599PubMed
26324116The march toward malaria vaccines.Vaccine2015https://conductscience.org/library/papers/26324116PubMed
25705207Montanide, Poly I:C and nanoparticle based vaccines promote differential suppressor and effector cell expansion: a study of induction of CD8 T cells to a minimal Plasmodium berghei epitope.Front Microbiol2015https://conductscience.org/library/papers/25705207PubMed
25115805Depletion of regulatory T cells augments a vaccine-induced T effector cell response against the liver-stage of malaria but fails to increase memory.PLoS One2014https://conductscience.org/library/papers/25115805PubMed
23875044A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.PLoS Negl Trop Dis2013https://conductscience.org/library/papers/23875044PubMed
23609325The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment.Sci Rep2013https://conductscience.org/library/papers/23609325PubMed
22576456Immunotherapy of cancer in 2012.CA Cancer J Clin2012https://conductscience.org/library/papers/22576456PubMed
22348325Bacterium-like particles as multi-epitope delivery platform for Plasmodium berghei circumsporozoite protein induce complete protection against malaria in mice.Malar J2012https://conductscience.org/library/papers/22348325PubMed
22275401Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.J Infect Dis2012https://conductscience.org/library/papers/22275401PubMed
22044118T-cell-inducing vaccines - what's the future.Immunology2012https://conductscience.org/library/papers/22044118PubMed
17328786Mannan-mediated gene delivery for cancer immunotherapy.Immunology2007https://conductscience.org/library/papers/17328786PubMed
17067310Enhanced major histocompatibility complex class I binding and immune responses through anchor modification of the non-canonical tumour-associated mucin 1-8 peptide.Immunology2006https://conductscience.org/library/papers/17067310PubMed
16622207
Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein.
Infect Immun2006https://conductscience.org/library/papers/16622207PubMed
15885121Building better T-cell-inducing malaria vaccines.Immunology2005https://conductscience.org/library/papers/15885121PubMed

See all 28 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9862371

GET https://conductscience.org/api/papers/v1/9862371/cited_by?page=2